Moderna and Merck shares soar on mRNA cancer vaccine - Axios
- Moderna and Merck shares soar on mRNA cancer vaccine Axios
- How Moderna Nearly Tripled Its Stock Price in a Single Day The New York Times
- 5 Reasons Why Moderna Stock Jumped 170% and How Far It Can Go Yahoo Finance
- Cancer vaccine from Moderna, Merck shows promise in late-stage trial; both stocks soar CNBC
- Moderna’s 177% Surge Burns Shorts in ‘Painful’ $5.5 Billion Loss Bloomberg.com
Related Markets
All MarketsMarket data may be delayed. Not financial advice.
💡 AI analysis provides alternative perspectives on current events